Russell Frank Company’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Russell Frank Company’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$4.24M	Sell	666,384 -181,761	-21%	-$933K	0.01%	1440
2015 Q4	$5.21M	Buy	848,145 +632,445	+293%	+$3.62M	0.01%	1260
2015 Q3	$1.29M	Buy	+215,700	New	+$1.5M	﹤0.01%	2088
2015 Q1	–	Sell	-17,827	Closed	-$123K	–	3067
2014 Q4	$123K	Hold	17,827	–	–	﹤0.01%	2705
2014 Q3	$145K	Hold	17,827	–	–	﹤0.01%	2596
2014 Q2	$126K	Buy	+17,827	New	+$135K	﹤0.01%	2616
2013 Q4	–	Sell	-31,138	Closed	-$253K	–	3129
2013 Q3	$253K	Buy	31,138 +19,202	+161%	+$155K	﹤0.01%	2702
2013 Q2	$89K	Buy	+11,936	New	+$91.6K	﹤0.01%	2769

Other funds holding SPPI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Russell Frank Company's SPPI Position: Q1 2016 in Review

Russell Frank Company reduced its Spectrum Pharmaceuticals Inc (SPPI) stake by 21% in Q1 2016, selling an estimated $933K and leaving 666,384 shares worth $4.24M. The position accounts for 0.01% of the portfolio, ranked #1440.

Russell Frank Company first reported a position in SPPI in Q2 2013 and has held it in 8 quarters since. The position peaked at $5.21M in Q4 2015. 131 funds tracked by Wall St. Rank hold SPPI as of Q1 2016.

Russell Frank Company held 666,384 shares of Spectrum Pharmaceuticals Inc worth $4.24M as of Q1 2016.
Russell Frank Company sold 181,761 Spectrum Pharmaceuticals Inc shares in Q1 2016, an estimated $933K.
Spectrum Pharmaceuticals Inc made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1440 holding.
Russell Frank Company first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and has held it in 8 quarters since.
Russell Frank Company's Spectrum Pharmaceuticals Inc position peaked at $5.21M in Q4 2015.
131 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.